Dr. Patricia Therese Illing: How Spliced Peptides Could Revolutionize Influenza Vaccines

The Michelson Medical Research Foundation and the Human Immunome Project (formerly Human Vaccines Project) hosted the first Annual Conference on the Future of Vaccine Development on June 27, 2018, at the USC Michelson Center for Convergent Bioscience.

The conference brought together leading scientists and researchers from around the world to discuss the latest advances in vaccines and to explore new ways to accelerate the development of vaccines against some of the world's most threatening diseases.

Michelson Prize Recipient: Dr. Patricia Therese Illing

Dr. Patricia Therese Illing is a research fellow at the Immunoproteomics Laboratory at Monash University in Melbourne, Australia. Her research focuses on the use of spliced peptides as vaccine candidates for influenza.

Spliced Peptides as Novel Candidates for Effective Influenza Immunity

In this video clip, Dr. Patricia Therese Illing discusses her research on spliced peptides for influenza immunity. She explains how spliced peptides can be used to target the immune system to specific parts of the influenza virus. Learn more about her medical research: https://research.monash.edu/en/persons/patricia-illing.